CooperVision today announced popular US television actress, producer, and entrepreneur Sarah Michelle Gellar as the spokesperson for its Brilliant Futures™ Myopia Management Program. Brilliant Futures™ is built around MiSight® 1 day, the first and only soft contact lens FDA-approved* to slow the progression of myopia in children ages 8-12 at the initiation of treatment†1. Read the full press release here.
Additionally, CooperVision has shared the following video featuring both Gellar and CooperVision leadership.
Sarah Michelle Gellar expressed her enthusiam for the partnership, saying “My husband and I are both nearsighted – and our myopia has continued to worsen over time. We want our kids to have a chance for better vision and lower their risk for future eye health issues. While regular eyeglasses or contacts help children see a whiteboard or tennis ball today, MiSight® 1 day lenses offer children the benefits of clear vision while slowing myopia progression during their growing years*. That is why I am thrilled to be partnering with CooperVision on this campaign.”
More information on the Brilliant Futures™ program and MiSight® 1 day contact lenses can be found on the Myopia Management Center page on the CooperVision practitioner web site.
†Compared to a single vision 1 day lens over a 3 year period.
References:
1 Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8): 556-567.
